This Report covers the highly-specialized area of patent litigation from the district courts to the Federal Circuit to the U.S. Supreme Court. Topics include infringement, claim interpretation, biotechnology issues, affirmative defenses, jurisdiction, discovery and insurance coverage. Published twice monthly.
Featured Stories
Unanimous High Court Says Microchip Sale Exhausted Patents
WASHINGTON, D.C. — In a unanimous opinion, the U.S. Supreme Court on June 9 held that the doctrine of patent exhaustion applies to method patents and is not nullified by a conditional sale, finding that computers manufactured by Quanta Computer Inc., which incorporate the patented technology of LG Electronics Inc. (LGE), are noninfringing despite license agreement provisions to the contrary (Quanta Computer Inc., et al. v. LG Electronics Inc., No. 06-937, U.S. Sup.; 2008 U.S. LEXIS 4702 . . . .
MedImmune, Genentech Agree To Dismiss Longstanding Patent Case
LOS ANGELES — The protracted dispute over the so-called Cabilly patent, a dispute that made it all the way to the U.S. Supreme Court, has been settled on remand (MedImmune Inc. v. Genentech Inc. et al., No. CV03-2567, C.D. Calif.). . . .